WallStreetZenWallStreetZen

NASDAQ: NEO
Neogenomics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NEO

Based on 4 analysts offering 12 month price targets for Neogenomics Inc

Min Forecast
$11.00-8.79%
Avg Forecast
$12.00-0.5%
Max Forecast
$14.00+16.09%

Should I buy or sell NEO stock?

Based on 4 analysts offering ratings for Neogenomics Inc.

Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NEO's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NEO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their NEO stock forecasts and price targets.

NEO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-12
lockedlocked$00.00+00.00%2025-09-12Find Out Why
lockedlocked$00.00+00.00%2025-09-02
lockedlocked$00.00+00.00%2025-08-04

1 of 1

Forecast return on equity

Is NEO forecast to generate an efficient return?

Company
8.89%
Industry
14.35%
Market
211.34%
NEO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NEO forecast to generate an efficient return on assets?

Company
5.42%
Industry
16.85%
NEO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NEO earnings per share forecast

What is NEO's earnings per share in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
$0.17
Avg 2 year Forecast
$0.37
Avg 3 year Forecast
$0.52

NEO revenue forecast

What is NEO's revenue in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
$803.4M+13.29%
Avg 2 year Forecast
$878.3M+23.86%
Avg 3 year Forecast
$970.8M+36.9%
NEO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NEO revenue growth forecast

How is NEO forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
10.79%
Industry
7.9%
Market
23.08%
NEO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NEO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NEO vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
NEO$12.06$12.00-0.50%Strong Buy
CSTL$39.39$48.00+21.86%Strong Buy
CDNA$20.55$21.50+4.62%Buy
OPK$1.26$1.93+52.78%Buy
NEOG$10.22$10.67+4.37%Buy
View Top Diagnostic & Research Stocks

Neogenomics Stock Forecast FAQ

Is Neogenomics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: NEO) stock is to Strong Buy NEO stock.

Out of 4 analysts, 3 (75%) are recommending NEO as a Strong Buy, 1 (25%) are recommending NEO as a Buy, 0 (0%) are recommending NEO as a Hold, 0 (0%) are recommending NEO as a Sell, and 0 (0%) are recommending NEO as a Strong Sell.

If you're new to stock investing, here's how to buy Neogenomics stock.

What is NEO's earnings growth forecast for 2026-2028?

(NASDAQ: NEO) Neogenomics's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 19.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.

Neogenomics's earnings in 2026 is -$113,468,000.On average, 15 Wall Street analysts forecast NEO's earnings for 2026 to be $21,788,906, with the lowest NEO earnings forecast at -$1,268,000, and the highest NEO earnings forecast at $41,028,872. On average, 12 Wall Street analysts forecast NEO's earnings for 2027 to be $47,537,078, with the lowest NEO earnings forecast at $30,432,011, and the highest NEO earnings forecast at $62,494,308.

In 2028, NEO is forecast to generate $66,647,656 in earnings, with the lowest earnings forecast at $55,792,020 and the highest earnings forecast at $80,155,743.

What is NEO's revenue growth forecast for 2026-2028?

(NASDAQ: NEO) Neogenomics's forecast annual revenue growth rate of 10.79% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.

Neogenomics's revenue in 2026 is $709,162,000.On average, 14 Wall Street analysts forecast NEO's revenue for 2026 to be $103,948,865,445, with the lowest NEO revenue forecast at $99,512,157,749, and the highest NEO revenue forecast at $109,650,985,835. On average, 11 Wall Street analysts forecast NEO's revenue for 2027 to be $113,646,481,130, with the lowest NEO revenue forecast at $107,526,438,143, and the highest NEO revenue forecast at $122,271,471,945.

In 2028, NEO is forecast to generate $125,614,852,723 in revenue, with the lowest revenue forecast at $120,929,720,449 and the highest revenue forecast at $132,363,720,423.

What is NEO's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: NEO) forecast ROA is 5.42%, which is lower than the forecast US Diagnostics & Research industry average of 16.85%.

What is NEO's Price Target?

According to 4 Wall Street analysts that have issued a 1 year NEO price target, the average NEO price target is $12.00, with the highest NEO stock price forecast at $14.00 and the lowest NEO stock price forecast at $11.00.

On average, Wall Street analysts predict that Neogenomics's share price could fall to $12.00 by Jan 12, 2027. The average Neogenomics stock price prediction forecasts a potential downside of 0.5% from the current NEO share price of $12.06.

What is NEO's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: NEO) Neogenomics's current Earnings Per Share (EPS) is -$0.88. On average, analysts forecast that NEO's EPS will be $0.17 for 2026, with the lowest EPS forecast at -$0.01, and the highest EPS forecast at $0.32. On average, analysts forecast that NEO's EPS will be $0.37 for 2027, with the lowest EPS forecast at $0.24, and the highest EPS forecast at $0.48. In 2028, NEO's EPS is forecast to hit $0.52 (min: $0.43, max: $0.62).

What is NEO's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: NEO) forecast ROE is 8.89%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.